APA (7th ed.) Citation

DB, P., M, V., A, R., M, G., TR, E., MDM, M., . . . J, D. (2026). Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes. Allergologia et immunopathologia, 54(4), 162. https://doi.org/10.15586/aei.v54i4.1449

Chicago Style (17th ed.) Citation

DB, Perez, et al. "Benralizumab Is Effective in Severe Asthma with CRS, Regardless of Demographic and Clinical Basal Outcomes." Allergologia Et Immunopathologia 54, no. 4 (2026): 162. https://doi.org/10.15586/aei.v54i4.1449.

MLA (9th ed.) Citation

DB, Perez, et al. "Benralizumab Is Effective in Severe Asthma with CRS, Regardless of Demographic and Clinical Basal Outcomes." Allergologia Et Immunopathologia, vol. 54, no. 4, 2026, p. 162, https://doi.org/10.15586/aei.v54i4.1449.